Aytu BioPharma Inc. (AYTU) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aytu BioPharma Inc.

    NASDAQ: AYTU · Real-Time Price · USD
    1.74
    -0.12 (-6.45%)
    At close: Sep 26, 2025, 3:59 PM
    1.84
    5.75%
    After-hours: Sep 26, 2025, 07:59 PM EDT

    Aytu BioPharma Balance Sheet Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Cash & Equivalents
    		 30.95M 20.01M 22.98M 19.36M 49.65M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a -1.38M n/a -10.91M
    Other Long-Term Assets
    		 1.2M 2.23M 792K 766K 465K
    Receivables
    		 31.16M 23.62M 28.94M 21.71M 28.18M
    Inventory
    		 11.43M 12.63M 11.99M 10.85M 16.34M
    Other Current Assets
    		 n/a n/a 868K 633K 1.29M
    Total Current Assets
    		 79.18M 61.89M 72.83M 59.93M 105.23M
    Property-Plant & Equipment
    		 1.59M 1.52M 3.87M 6.3M 8.7M
    Goodwill & Intangibles
    		 42.2M 52.45M 58.97M 70.63M 151.27M
    Total Long-Term Assets
    		 45M 56.2M 63.63M 77.69M 160.43M
    Total Assets
    		 124.18M 118.09M 136.46M 137.62M 265.67M
    Account Payables
    		 10.6M 10.44M 13.48M 10.99M 19.25M
    Deferred Revenue
    		 n/a n/a 46.8M n/a 57.23M
    Short-Term Debt
    		 1.86M 4.25M 1.56M 3.81M 24.6M
    Other Current Liabilities
    		 50.61M 18.02M 157K 15.89M 1.47M
    Total Current Liabilities
    		 63.06M 62.23M 69.02M 64.44M 109.44M
    Long-Term Debt
    		 10.89M 10.88M 14.71M 14.2M 2.8M
    Other Long-Term Liabilities
    		 30.27M 16.7M 12.55M 14.59M 13.23M
    Total Long-Term Liabilities
    		 42.15M 28.15M 28.09M 28.87M 18.66M
    Total Liabilities
    		 105.21M 90.38M 97.11M 93.31M 128.1M
    Total Debt
    		 1.86M 16.42M 18.45M 18.19M 28.35M
    Book Value
    		 18.97M 27.72M 39.36M 44.31M 137.57M
    Book Value Per Share
    		 3.02 5.00 11.78 30.14 163.77
    Common Stock
    		 1K 1K 1K 4K 3K
    Retained Earnings
    		 -333.54M -319.97M -304.13M -287.08M -178.3M
    Comprehensive Income
    		 n/a n/a n/a n/a n/a
    Shareholders Equity
    		 18.97M 27.72M 39.36M 44.31M 137.57M
    Total Investments
    		 n/a -762K -1.38M n/a -10.91M

    Add to Watchlist